| |
| |
|
| Insider
Information: |
Baity Glenn |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
83,734 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,238,426 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
83,734 |
|
|
| Total
Value |
$1,238,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
|
2018-01-29 |
83,734 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
VP, GC & Sec.Officer |
• – – |
2010-03-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,203 |
|
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2012-11-27 |
4 |
AS |
$6.28 |
$101,754 |
D/D |
(16,206) |
47,559 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2012-11-28 |
4 |
AS |
$5.25 |
$23,090 |
D/D |
(4,396) |
43,163 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-02 |
4 |
AS |
$8.00 |
$105,304 |
D/D |
(13,163) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-11 |
4 |
OE |
$1.55 |
$47,200 |
D/D |
30,000 |
50,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-11 |
4 |
AS |
$11.06 |
$360,600 |
D/D |
(30,000) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-12 |
4 |
AS |
$12.74 |
$384,800 |
D/D |
(30,000) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-12 |
4 |
OE |
$1.55 |
$47,200 |
D/D |
30,000 |
50,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-15 |
4 |
OE |
$1.55 |
$31,000 |
D/D |
20,000 |
60,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-15 |
4 |
AS |
$12.50 |
$250,000 |
D/D |
(20,000) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-16 |
4 |
OE |
$1.55 |
$31,000 |
D/D |
20,000 |
60,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-16 |
4 |
AS |
$12.30 |
$246,000 |
D/D |
(20,000) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-17 |
4 |
AS |
$12.26 |
$122,600 |
D/D |
(10,000) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-17 |
4 |
OE |
$1.55 |
$15,500 |
D/D |
10,000 |
50,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-22 |
4 |
OE |
$1.62 |
$16,200 |
D/D |
10,000 |
50,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2013-04-22 |
4 |
AS |
$13.15 |
$131,493 |
D/D |
(10,000) |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2014-02-26 |
4 |
OE |
$6.17 |
$259,140 |
D/D |
42,000 |
89,788 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
VP AND GC |
• – – |
2014-02-26 |
4 |
AS |
$30.28 |
$1,271,718 |
D/D |
(42,000) |
47,788 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2014-12-09 |
4 |
OE |
$1.55 |
$12,400 |
D/D |
8,000 |
62,423 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2016-03-02 |
4 |
AS |
$20.80 |
$145,580 |
D/D |
(7,000) |
62,921 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2016-03-02 |
4 |
OE |
$15.37 |
$107,590 |
D/D |
7,000 |
69,921 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2016-07-11 |
4 |
OE |
$6.78 |
$27,506 |
D/D |
4,057 |
66,978 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2016-07-11 |
4 |
AS |
$35.00 |
$142,001 |
D/D |
(4,057) |
62,921 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2016-07-12 |
4 |
OE |
$6.78 |
$80,974 |
D/D |
11,943 |
74,864 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP AND GC |
• – – |
2016-07-12 |
4 |
AS |
$35.00 |
$418,031 |
D/D |
(11,943) |
62,921 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
